[The use of albumin infusion in decompensated liver cirrhosis].

Abstract

For patients with refractory ascites, paracentesis is the standard therapy and for many it is the only treatment option. When more than five litres of ascitic fluid are removed, the use of a plasma expander effectively prevents "postparacentesis circulatory dysfunction", which is associated with a high mortality. Randomised controlled studies show that albumin is more effective than synthetic plasma expanders in the prevention of this complication. In selected patients with ascites, long-term administration of albumin may improve the diuretic response. A randomised controlled study in patients with spontaneous bacterial peritonitis has demonstrated that treatment with albumin infusion in addition to an antibiotic reduces the incidence of hepatorenal syndrome. Albumin infusion in combination with the administration of a vasopressin analogue may be able to reverse established hepatorenal syndrome; however, no controlled studies have been published. Whereas the use of albumin infusion with large-volume paracentesis is strongly supported by the available evidence, additional conclusive studies of the use of albumin for spontaneous bacterial peritonitis are awaited.

• Authors: Lars E Schmidt, Helmer Ring-Larsen
• Journal: Ugeskrift for laeger (Ugeskr Laeger) Vol. 164 Issue 9 Pg. 1196-202 (Feb 25 2002) ISSN: 0041-5782 [Print] Denmark
• Vernacular Title: Anvendelse af human albumin-infusion ved dekompenseret levercirrose.
• PMID: 11899505 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Plasma Substitutes
• Serum Albumin

Topics

• Ascites (drug therapy, prevention & control, surgery)
• Hepatorenal Syndrome (drug therapy, prevention & control)
• Humans
• Infusions, Intravenous
• Liver Cirrhosis (complications, drug therapy, physiopathology)
• Meta-Analysis as Topic
• Paracentesis
• Peritonitis (drug therapy, microbiology, prevention & control)
• Plasma Substitutes (administration & dosage)
• Randomized Controlled Trials as Topic
• Serum Albumin (administration & dosage)